Product Information
METHYLPHENIDATE CD 50 MG CAP is a generic product labeled by Lannett Company Inc., priced at $1.4958 per EA under NDC 00527458337. Its NADAC has been published 378 times since Apr 3, 2019.
Strength
50 mg/1
Manufacturer
Lannett Company Inc.NDC
00527458337
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021259On Market Since
3/21/2006
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE CD 50 MG CAP has been published 378 times since Apr 3, 2019, and over the history we have for it it has declined 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4958 per EA |
|---|---|
| All-time high | $4.4589 (Apr 10, 2019) |
| All-time low | $1.1295 (May 22, 2024) |
| 52-week high | $2.0701 |
| 52-week low | $1.4472 |
| Median price | $2.2054 |
| Average price | $2.3285 |
| Largest weekly change | +42.5% (Jan 19, 2022) |
| Weeks tracked | 378 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE CD 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE CD 50 MG CAP, manufactured by Lannett Company Inc., is $1.4958 per EA (NDC 00527458337), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE CD 50 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE CD 50 MG CAP has declined 66.5%. It has been tracked across 378 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE CD 50 MG CAP?
Since Apr 3, 2019, the NADAC for METHYLPHENIDATE CD 50 MG CAP has ranged from a low of $1.1295 (May 22, 2024) to a high of $4.4589 (Apr 10, 2019), with a median of $2.2054 per EA.
Are there cheaper alternatives to METHYLPHENIDATE CD 50 MG CAP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE CD 50 MG CAP, but none are currently priced below it.
Who manufactures METHYLPHENIDATE CD 50 MG CAP?
METHYLPHENIDATE CD 50 MG CAP (NDC 00527458337) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification